Age-related Macular Degeneration (AMD) Market
The Age-related Macular Degeneration (AMD) market consists of treatments, primarily pharmaceuticals, for a common eye condition affecting older adults. The primary customers are individuals within the aging global population who suffer from eye-related diseases. Key growth drivers include the rising prevalence of these conditions in an aging demographic and an increasing number of refractive eye surgeries, which often lead to earlier diagnosis of AMD.
CAGR
8%
Compound Annual Growth Rate
Current Value
$13.7B
Estimated 2026
Projected Value
$25.4B
By 2034
Get full access to
this market report
Sign up to unlock detailed analysis, startup opportunities, and competitive insights for "Age-related Macular Degeneration (AMD) Market".
Opportunity & Timing Scores
Barrier Analysis (Capital, Technical, Regulatory)
Key Players & Competitive Landscape
Curated Startup Ideas
7-day free trial
Cancel anytime
Secure payment